These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3022888)
1. Interaction of beta-casomorphins with multiple opioid receptors: in vitro and in vivo studies in the newborn rat brain. Volterra A; Restani P; Brunello N; Galli CL; Racagni G Brain Res; 1986 Nov; 395(1):25-30. PubMed ID: 3022888 [TBL] [Abstract][Full Text] [Related]
2. Opioid activities of human beta-casomorphins. Koch G; Wiedemann K; Teschemacher H Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):351-4. PubMed ID: 3005882 [TBL] [Abstract][Full Text] [Related]
3. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery. Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F Peptides; 1982; 3(5):793-7. PubMed ID: 6294635 [TBL] [Abstract][Full Text] [Related]
4. Ontogenetic studies on mu, delta and kappa opioid receptors in rat brain. Volterra A; Brunello N; Restani P; Galli CL; Racagni G Pharmacol Res Commun; 1986 Oct; 18(10):979-90. PubMed ID: 3027723 [TBL] [Abstract][Full Text] [Related]
5. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain. Khawaja XZ; Green IC; Thorpe JR; Titheradge MA Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240 [TBL] [Abstract][Full Text] [Related]
6. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex. Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of novel casomorphin analogues: binding profiles towards mu 1-, mu 2- and delta -opioid receptors. Liebmann C; Schnittler M; Hartrodt B; Born I; Neubert K Pharmazie; 1991 May; 46(5):345-8. PubMed ID: 1654566 [TBL] [Abstract][Full Text] [Related]
10. Endogenous opioid peptides: comparative evaluation of their receptor affinities in the mouse brain. Garzón J; Sánchez-Blázquez P; Höllt V; Lee NM; Loh HH Life Sci; 1983; 33 Suppl 1():291-4. PubMed ID: 6319879 [TBL] [Abstract][Full Text] [Related]
11. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
12. A novel cyclic opioid peptide analog showing high preference for mu-receptors. Schiller PW; Nguyen TM; Maziak L; Lemieux C Biochem Biophys Res Commun; 1985 Mar; 127(2):558-64. PubMed ID: 2983726 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain. Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574 [TBL] [Abstract][Full Text] [Related]
14. Identification of distinct binding site subunits of mu and delta opioid receptors. Howard AD; Sarne Y; Gioannini TL; Hiller JM; Simon EJ Biochemistry; 1986 Jan; 25(2):357-60. PubMed ID: 3006757 [TBL] [Abstract][Full Text] [Related]
15. Interactions between the antiopiate Tyr-MIF-1 and the mu opiate morphiceptin at their respective binding sites in brain. Zadina JE; Kastin AJ Peptides; 1985; 6(5):965-70. PubMed ID: 2867527 [TBL] [Abstract][Full Text] [Related]
16. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency. Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074 [TBL] [Abstract][Full Text] [Related]
18. Differential postnatal development of mu and delta opiate receptors. Wohltmann M; Roth BL; Coscia CJ Brain Res; 1982 Apr; 255(4):679-84. PubMed ID: 6280810 [TBL] [Abstract][Full Text] [Related]
19. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding. Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727 [TBL] [Abstract][Full Text] [Related]
20. Interactions of N-cyclopropylmethyl(-)-6 beta-acetylthionormorphine with mu-, kappa-, delta- and sigma-opioid receptors. Takayanagi I; Koike K; Satoh M Gen Pharmacol; 1991; 22(5):965-7. PubMed ID: 1662176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]